Literature DB >> 24847333

Salt Loading Promotes Kidney Injury via Fibrosis in Young Female Ren2 Rats.

Javad Habibi1, Melvin R Hayden2, Carlos M Ferrario3, James R Sowers4, Adam T Whaley-Connell5.   

Abstract

BACKGROUND/AIMS: It is increasingly recognized that there is sexual dimorphism in kidney disease progression; however, this disparity is lost in the presence of diabetes where women progress at a similar rate to men. The renin-angiotensin-aldosterone system (RAAS) is known to regulate diabetes-induced kidney injury, and recent literature would suggest that gender differences exist in RAAS-dependent responses in the kidney. In this regard, these gender differences may be overcome by excessive salt intake. Thereby, we hypothesized that salt would promote proteinuria in transgenic female rats under conditions of excess tissue angiotensin (Ang) II and circulating aldosterone.
MATERIALS AND METHODS: We utilized young female transgenic (mRen2)27 (Ren2) rats and Sprague-Dawley (SD) littermates and fed a high-salt diet (4%) over 3 weeks.
RESULTS: Compared to SD and Ren2 controls, female Ren2 rats fed a high-salt diet displayed increases in proteinuria, periarterial and interstitial fibrosis as well as ultrastructural evidence of basement membrane thickening, loss of mitochondrial elongation, mitochondrial fragmentation and attenuation of basilar canalicular infoldings. These findings occurred temporally with increases in transforming growth factor-β but not indices of oxidant stress.
CONCLUSIONS: Our current data suggest that a diet high in salt promotes progressive kidney injury as measured by proteinuria and fibrosis associated with transforming growth factor-β under conditions of excess tissue Ang II and circulating aldosterone.

Entities:  

Keywords:  Angiotensin II; Fibrosis; Proteinuria; Reactive oxygen species; Transgenic (mRen2)27 rat

Year:  2014        PMID: 24847333      PMCID: PMC4025048          DOI: 10.1159/000360866

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  37 in total

1.  Aldosterone, dietary salt, and renal disease.

Authors:  Eduardo Pimenta; David A Calhoun
Journal:  Hypertension       Date:  2006-06-26       Impact factor: 10.190

Review 2.  Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?

Authors:  Wilhelm Kriz; Brigitte Kaissling; Michel Le Hir
Journal:  J Clin Invest       Date:  2011-02       Impact factor: 14.808

3.  Effect of gender on the progression of nondiabetic renal disease: a meta-analysis.

Authors:  Joel Neugarten; Anjali Acharya; Sharon R Silbiger
Journal:  J Am Soc Nephrol       Date:  2000-02       Impact factor: 10.121

4.  Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2.Lewis rat.

Authors:  Sarah H Lindsey; Liliya M Yamaleyeva; K Bridget Brosnihan; Patricia E Gallagher; Mark C Chappell
Journal:  Hypertension       Date:  2011-08-15       Impact factor: 10.190

5.  Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression.

Authors:  Mihaela C Blendea; David Jacobs; Craig S Stump; Samy I McFarlane; Cristina Ogrin; Gul Bahtyiar; Samir Stas; Pawan Kumar; Quan Sha; Carlos M Ferrario; James R Sowers
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-10-19       Impact factor: 4.310

Review 6.  TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy.

Authors:  Claire E Hills; Paul E Squires
Journal:  Am J Nephrol       Date:  2009-11-04       Impact factor: 3.754

7.  Differential effects of 17beta-estradiol and of synthetic progestins on aldosterone-salt-induced kidney disease.

Authors:  Paula-Anahi Arias-Loza; Melanie Muehlfelder; Susan A Elmore; Robert Maronpot; Kai Hu; Hartmut Blode; Christa Hegele-Hartung; Karl Heinrich Fritzemeier; Georg Ertl; Theo Pelzer
Journal:  Toxicol Pathol       Date:  2009-12       Impact factor: 1.902

8.  Angiotensin II induces apoptosis in renal proximal tubular cells.

Authors:  Madhu Bhaskaran; Krishna Reddy; Neetu Radhakrishanan; Nicholas Franki; Guohua Ding; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2003-01-14

Review 9.  Therapy for fibrotic diseases: nearing the starting line.

Authors:  Scott L Friedman; Dean Sheppard; Jeremy S Duffield; Shelia Violette
Journal:  Sci Transl Med       Date:  2013-01-09       Impact factor: 17.956

10.  Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.

Authors:  James M Luther; Pengcheng Luo; Zuofei Wang; Samuel E Cohen; Hyung-Suk Kim; Agnes B Fogo; Nancy J Brown
Journal:  Kidney Int       Date:  2012-05-23       Impact factor: 10.612

View more
  4 in total

1.  Benefical therapeutic effect of Chinese Herbal Xinji'erkang formula on hypertension-induced renal injury in the 2-kidney-1-clip hypertensive rats.

Authors:  Ling-Ling Huang; Chen Pan; Ting-Ting Yu; Kun Guo; Xing-Hui Wang; Jun-Yan Zhang; Hong-Zhi Wang; Shan Gao
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-08-23

Review 2.  The role of transforming growth factor β1 in the regulation of blood pressure.

Authors:  Kota Matsuki; Catherine K Hathaway; Marlon G Lawrence; Oliver Smithies; Masao Kakoki
Journal:  Curr Hypertens Rev       Date:  2014

3.  Dietary Sodium Restriction Reduces Arterial Stiffness, Vascular TGF-β-Dependent Fibrosis and Marinobufagenin in Young Normotensive Rats.

Authors:  Yulia N Grigorova; Wen Wei; Natalia Petrashevskaya; Valentina Zernetkina; Ondrej Juhasz; Rachel Fenner; Christian Gilbert; Edward G Lakatta; Joseph I Shapiro; Alexei Y Bagrov; Olga V Fedorova
Journal:  Int J Mol Sci       Date:  2018-10-15       Impact factor: 5.923

4.  Efficacy and safety of a low-sodium diet and spironolactone in patients with stage 1-3a chronic kidney disease: a pilot study.

Authors:  Hongmei Zhang; Bin Zhu; Liyang Chang; Xingxing Ye; Rongrong Tian; Luchen He; Dongrong Yu; Hongyu Chen; Yongjun Wang
Journal:  BMC Nephrol       Date:  2022-03-05       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.